INDGN

Indegene Share Price

 

Stock touched 52W low

 

Invest in Indegene with 3.41X leverage

Invest with MTF

Performance

  • Low
  • ₹493
  • High
  • ₹508
  • 52 Week Low
  • ₹493
  • 52 Week High
  • ₹682
  • Open Price₹507
  • Previous Close₹507
  • Volume151,274
  • 50 DMA₹525.24
  • 100 DMA₹536.60
  • 200 DMA₹552.21

Investment Returns

  • Over 1 Month -5.41%
  • Over 3 Month -8.02%
  • Over 6 Month -14.57%
  • Over 1 Year -22.43%

Smart Investing Starts Here Start SIP with Indegene for Steady Growth!

Invest Now

Indegene Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 26.8
  • PEG Ratio
  • 1.4
  • Market Cap Cr
  • 11,929
  • P/B Ratio
  • 4.2
  • Average True Range
  • 9.66
  • EPS
  • 18.54
  • Dividend Yield
  • 0.4
  • MACD Signal
  • -3.57
  • RSI
  • 26.47
  • MFI
  • 32.38

Indegene Financials

Indegene Technicals

EMA & SMA

Current Price
₹496.55
-10.05 (-1.98%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹517.04
  • 50 Day
  • ₹525.24
  • 100 Day
  • ₹536.60
  • 200 Day
  • ₹552.21

Resistance and Support

499.05 Pivot Speed
  • R3 520.75
  • R2 514.35
  • R1 505.45
  • S1 490.15
  • S2 483.75
  • S3 474.85

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Indegene is a global healthcare solutions company providing commercial, medical, and digital transformation services to life sciences companies. It helps pharmaceutical, biotech, and healthcare organizations enhance patient outcomes through data-driven strategies and innovative technology solutions.

Indegene Ltd has an operating revenue of Rs. 3,041.00 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 19% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 89 which is a GOOD score indicating consistency in earnings, a RS Rating of 46 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 99 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Indegene Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-10-30 Quarterly Results
2025-07-31 Quarterly Results
2025-04-28 Audited Results & Final Dividend
2025-01-30 Quarterly Results & Others To consider other business matters. per share(100%)Final Dividend
2024-10-28 Quarterly Results
Date Purpose Remarks
2025-06-13 FINAL Rs.2.00 per share(100%)Final Dividend
View Indegene Dividend History Arrow

Indegene F&O

Indegene Shareholding Pattern

0%
3.07%
0.01%
11.3%
13.28%
72.34%

Indegene FAQs

Indegene share price is ₹496 As on 17 January, 2026 | 14:35

The Market Cap of Indegene is ₹11928.6 Cr As on 17 January, 2026 | 14:35

The P/E ratio of Indegene is 26.8 As on 17 January, 2026 | 14:35

The PB ratio of Indegene is 4.2 As on 17 January, 2026 | 14:35

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23